Celltrion | 068270 - Net Income

Stock Price
209,500.00
Daily Change
3,500.00 1.70%
Monthly
-14.31%
Yearly
11.91%
Q1 Forecast
195,060.60

Celltrion reported KRW331.35B in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
Akebia Therapeutics USD 6.11M 28.92M Mar/2025
Alaunos Therapeutics USD -1.16M 417K Sep/2025
Avita Medical AUD -11.62M 1.7M Dec/2025
Celltrion KRW 331.35B 270.18B Sep/2025
Dianthus Therapeutics USD -36.76M 5.13M Sep/2025
Ionis Pharmaceuticals USD -229M 100.39M Dec/2025
IQVIA Holdings USD 514M 183M Dec/2025
Moderna USD -200M 625M Sep/2025
Organon & Co USD 160M 15M Sep/2025
Revvity USD 98.36M 51.71M Dec/2025
Tectonic Therapeutic USD -19.04M 940K Sep/2025
Viatris USD -340.1M 211.9M Dec/2025
Xeris Pharmaceuticals USD 621K 2.55M Sep/2025